Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.79 USD
Change Today -0.76 / -4.89%
Volume 119.8K
LIFE On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John D. Mendlein Ph.D., J.D.

Executive Chairman and Chief Executive Officer,aTyr Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 67 board members in 5 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. John D. Mendlein, Ph.D., J.D. has been the Chief Executive Officer of aTyr Pharma Inc. since September 2011 and has been its Executive Chairman since May 2010. Dr. Mendlein served as the Chief Executive Officer of Compound Therapeutics. Dr. Mendlein was the founder of Alevium Pharmaceuticals Inc., and served as its Chairman and Chief Executive Officer. He founded Fate Therapeutics, Inc. in 2007 and served as its Executive Chairman. Previously, Dr. Mendlein served ...

Read Full Background

Corporate Headquarters*

3545 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-731-8389
Fax: 858-731-8394

Board Members Memberships*

Vice Chairman of the Board
Executive Chairman and Chief Executive Officer


University of California-Los Angeles
University of Miami
Hastings College of Law

Other Affiliations*

Annual Compensation*

Total Annual Compensation$410,000

Stock Options*

Restricted Stock Awards$268,089
All Other Compensation$38,407
Exercisable Options1,357,875
Exercisable Options Value$1,754,846
Unexercisable Options1,628,409
Unexercisable Options Value$1,891,891
Total Value of Options$3,646,736
Total Number of Options2,986,284

Total Compensation*

Total Annual Cash Compensation$525,282
Total Short Term Compensation$410,000
Other Long Term Compensation$306,496
Total Calculated Compensation$1,397,977
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LIFE:US $14.79 USD -0.76


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATYR PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at